Year archive

NAVCO Pharmaceuticals — 2023 filings

All 20 regulatory filings released by NAVCO Pharmaceuticals (NAV) in 2023, sourced directly from the official regulator.

20 Filings

2023 Period

2023 filings (20)

Filing	Released	Lang
Notice (amended).pdf Capital/Financing Update	2023-09-20	English
Financial statements of RTO acquirer.pdf Interim / Quarterly Report	2023-09-20	English
Financial statements of RTO acquirer.pdf Audit Report / Information	2023-09-20	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-08-30	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-08-30	English
Interim MD&A - English.pdf Management Reports	2023-08-30	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-08-30	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-05-31	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-05-31	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-05-30	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-05-30	English
Other securityholders documents - English.pdf Board/Management Information	2023-04-22	English
Other.pdf Regulatory Filings	2023-04-18	English
Other.pdf Regulatory Filings	2023-04-18	English
Material change report - English.pdf Regulatory Filings	2023-04-14	English
News release - English.pdf Capital/Financing Update	2023-04-13	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2023-02-27	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2023-02-27	English
Interim MD&A - English.pdf Interim / Quarterly Report	2023-02-27	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2023-02-27	English